BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Genentech

Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions and over 50 projects in the pipeline. The company is the leading provider of anti-tumor therapeutics in the United States. With its strength in all areas of the drug development process — from research and development to manufacturing and commercialization — Genentech continues to transform innovative science into breakthrough therapies for patients. For more general information about the company, visit our corporate overview section.


Contact Details:
1 DNA Way
South San Francisco
CA
94080
United States of America
Tel:650 225 1000
Fax:650 225 6000
Email:
WWW:

www.gene.com/




Loading...

Recent Publications by Genentech:

Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.
Although Akt is known as a survival kinase, inhibitors of the...
8th October, 2008
Genentech, Inc., South San Francisco, CA 94080, USA. J Cell Biol. 2008 Oct 6;183(1):101-16.
DOI Direct Link
The Filamentous Actin Cross-Linking/Bundling Activity of Mammalian Formins.
Formins are multidomain proteins that regulate actin filament dynamics and...
7th October, 2008
Department of Chemical and Biomolecular Engineering, Johns Hopkins J Mol Biol. 2008 Sep 26.
DOI Direct Link
Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction.
Disruption or improper activation of the Hedgehog (Hh) pathway is...
2nd October, 2008
Department of Molecular Biology, Genentech, South San Francisco, CA 94080, Sci Signal. 2008 Sep 30;1(39):ra7.
DOI Direct Link
Reactive hyperemia and BOLD MRI demonstrate that VEGF inhibition, age, and atherosclerosis adversely affect functional recovery in a murine model of peripheral artery disease.
PURPOSE: To develop magnetic resonace imaging (MRI) methods for functional...
30th September, 2008
Department of Biomedical Imaging, Genentech, Inc., South San Franscisco, J Magn Reson Imaging. 2008 Sep 26;28(4):996-1004.
DOI Direct Link
Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma.
BACKGROUND: The underlying reasons for racial disparities in asthma...
26th September, 2008
Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Ann Allergy Asthma Immunol. 2008 Sep;101(3):256-63.

View more Genentech research publications.

BioNews Results for Genentech:

Pipeline, Partnerships, and Presentations: Genentech Commits to Ophthalmology
Retina Today:  Oct 12 2008 3:27AM Matching: genentech
Diabetic Macular Edema: Treatment Updates 2008
Retina Today:  Oct 12 2008 3:26AM Matching: genentech
Update on the Diabetic Retinopathy Clinical Research Network
Retina Today:  Oct 12 2008 3:25AM Matching: genentech
Diabetic Retinopathy and Inflammation
Retina Today:  Oct 12 2008 3:24AM Matching: genentech
?Focal/Grid Photocoagulation More Effective Treatment than IVTA for DME
Retina Today:  Oct 12 2008 1:50PM Matching: genentech
Promote your company here: BioNewsCast - Press Release Distribution

View more Genentech news.

Genentech Patents:

US Patent No.Title
7393917 PRO1482 polypeptides
7405268 Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
7407660 Methods and compositions for selective modulation of vascularization
7407785 Human DNase I hyperactive variants

View more Genentech patents.

Genentech (DNA) Financial information Links from Barchart

DNA Quote from from Barchart.com
DNA Chart from from Barchart.com
DNA Profile from from Barchart.com
DNA Opinion from from Barchart.com

View more Genentech finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 581 individuals from Genentech using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 225 times since April 2007, the link to the organisation's website has been followed 53 times

Recent Search Terms used to find this page: genentech hae1 2008 | genentech uk | genentech uk | Genentech UK Ltd. | genentech HER3 | genentech | t | .

Search for more companies in South San Francisco

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genentech
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.